Home Cart Sign in  
Chemical Structure| 91978-69-7 Chemical Structure| 91978-69-7

Structure of p-Cresyl sulfate potassium
CAS No.: 91978-69-7

Chemical Structure| 91978-69-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

p-Methylphenyl potassium sulfate is a prototype protein-bound uremic toxin

Synonyms: p-Tolyl sulfate potassium; p-Cresol sulfate (potassium salt); para-Cresol sulfate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of p-Cresyl sulfate potassium

CAS No. :91978-69-7
Formula : C7H7KO4S
M.W : 226.29
SMILES Code : O=S(OC1=CC=C(C)C=C1)([O-])=O.[K+]
Synonyms :
p-Tolyl sulfate potassium; p-Cresol sulfate (potassium salt); para-Cresol sulfate
MDL No. :MFCD28100835
InChI Key :HTSFIPMTBJHYFQ-UHFFFAOYSA-M
Pubchem ID :91972090

Safety of p-Cresyl sulfate potassium

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
H9c2 cardiomyoblasts 250, 500, 1000 µM 24 hours To investigate the effect of PCS on apoptosis in H9c2 cells. Results showed that PCS increased apoptosis in a dose-dependent manner, upregulated Bax expression, downregulated Bcl-2 expression, and increased caspase-3 activity. J Am Heart Assoc. 2015 Jun 11;4(6):e001852
BV2 microglia 0.1, 0.5, 1, 5, 10, 50, 150 µM 24 hours To investigate the effect of pCS on ADAM10 and ADAM17 expression in BV2 microglia. Results showed that pCS reduced ADAM17 expression and, at high concentrations, decreased ADAM10 expression. Int J Mol Sci. 2022 Sep 20;23(19):11013
H9C2 cardiomyoblasts 3.125, 6.25, 12.5 and 25.0 µg/mL 3 days To investigate the effect of PCS on mitochondrial function in H9C2 cardiomyoblasts, results showed that 6.25 µg/mL PCS induced mitochondrial hyperfusion with enhanced mitochondrial connectivity, mitochondrial oxygen consumption rates, mitochondrial mass, mitochondrial DNA copy number and increased volume of cardiomyoblasts. J Cell Mol Med. 2020 Aug;24(15):8379-8390
THP-1 human monocyte cells 100 µg/mL 3 hours To investigate the effects of p-cresyl sulfate and indoxyl sulfate on ILK activity in THP-1 cells. Results showed that p-cresyl sulfate at 100 µg/mL significantly increased GSK-3β phosphorylation levels after 3 hours of incubation. Exp Mol Med. 2022 Mar;54(3):226-238

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice 5/6 nephrectomy model Oral gavage 100 mg/kg Once daily for 8 weeks To investigate the effect of PCS on cardiac function. Results showed that PCS aggravated diastolic dysfunction in 5/6 nephrectomized mice, increased cardiomyocyte apoptosis, and enhanced collagen deposition. J Am Heart Assoc. 2015 Jun 11;4(6):e001852
C57BL/6 mice Acute kidney injury (AKI) model induced by unilateral ischemia and reperfusion (IR) injury Intraperitoneal injection 20, 40, or 60 mg/L/day Once daily for 15 days To evaluate the effects of p-cresyl sulfate (PCS) on the kidney and heart in animals subjected to AKI induced by ischemia and reperfusion (IR) injury. Results showed that a 20 mg/L dose of PCS led to a decrease in renal mass, an increase in the gene expression of Cystatin C and kidney injury molecule 1 (KIM-1), and a decrease in the α-actin in the heart. During AKI, PCS increased the renal injury biomarkers compared to control; however, it did not exacerbate these markers. Furthermore, PCS did not enhance the cardiac hypertrophy observed after 15 days of IR. Toxins (Basel). 2023 Nov 10;15(11):649

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.42mL

0.88mL

0.44mL

22.10mL

4.42mL

2.21mL

44.19mL

8.84mL

4.42mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
 

Historical Records

Categories